Asia Spotlight: Emerging Markets At Stake As Viehbacher Departs Sanofi?
Executive Summary
As emerging markets represent 32% of Sanofi’s overall sales, the highest among big pharma firms, will the sudden departure of Viehbacher leave a dent in one of the firm’s key growth platforms?